pSBbi-RP-CoV2/RBD-puro Citations (2)
Originally described in: Stable production of recombinant SARS-CoV-2 receptor-binding domain in mammalian cells with co-expression of a fluorescent reporter and its validation as antigenic target for COVID-19 serology testing.Arias-Arias JL, Molina-Castro SE, Monturiol-Gross L, Lomonte B, Corrales-Aguilar E Biotechnol Rep (Amst). 2023 Mar;37:e00780. doi: 10.1016/j.btre.2022.e00780. Epub 2022 Dec 31. PubMed Journal
Articles Citing pSBbi-RP-CoV2/RBD-puro
| Articles |
|---|
Stable production of recombinant SARS-CoV-2 receptor-binding domain in mammalian cells with co-expression of a fluorescent reporter and its validation as antigenic target for COVID-19 serology testing.
Arias-Arias JL, Molina-Castro SE, Monturiol-Gross L, Lomonte B, Corrales-Aguilar E.
Biotechnol Rep (Amst). 2023 Mar;37:e00780. doi: 10.1016/j.btre.2022.e00780. Epub 2022 Dec 31.
PubMed
Associated Plasmids |
| A Live-Cell Imaging-Based Fluorescent SARS-CoV-2 Neutralization Assay by Antibody-Mediated Blockage of Receptor Binding Domain-ACE2 Interaction. Arias-Arias JL, Monturiol-Gross L, Corrales-Aguilar E. BioTech (Basel). 2025 Feb 14;14(1):10. doi: 10.3390/biotech14010010. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.